<?xml version="1.0" encoding="UTF-8"?><Legislation SchemaVersion="1.0" xsi:schemaLocation="http://www.tso.co.uk/assets/namespace/legislation C:\development\projects\ActsToSchema\legislationSchema\schema\schemaLegislationBase-v1-0.xsd" xmlns="http://www.tso.co.uk/assets/namespace/legislation" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:leg="http://www.tso.co.uk/assets/namespace/legislation" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ukm="http://www.tso.co.uk/assets/namespace/metadata" xmlns:fo="http://www.w3.org/1999/XSL/Format">
<ukm:Metadata>
<dc:title>Medical Innovation Bill</dc:title>
<dc:identifier>ISBN TO GO HERE</dc:identifier>
<dc:language>en</dc:language>
<dc:creator>Parliamentary Counsel</dc:creator>
<dc:date>16/5/2013</dc:date>
<ukm:BillMetadata>
<ukm:DocumentClassification>
<ukm:DocumentCategory Value="Bill" />
<ukm:DocumentMainType Value="PublicBill" />
<ukm:DocumentStatus Value="final" />
</ukm:DocumentClassification>
<ukm:Number Value="Bill 21" />
<ukm:Parliament Value="55" />
<ukm:Session Value="3" />
<ukm:House Value="House of Lords" />
</ukm:BillMetadata>
</ukm:Metadata>
<Cover>
<CoverTitle>EXPLANATORY NOTES</CoverTitle>
<CoverPara><Text><?start-line?>Explanatory notes to the Bill, prepared by Lord Saatchi, the Member in charge of the <?new-line?>Bill, are published separately as HL Bill 21—EN.</Text></CoverPara>
</Cover><Contents>
<Rubric TemplateVersion="4.2.002" xmlns="" /><Rubric xmlns="" /><ContentsTitle>Contents</ContentsTitle>
<ContentsItem ContentRef="p00003">
<ContentsNumber>1</ContentsNumber>
<ContentsTitle>Responsible innovation</ContentsTitle>
</ContentsItem>
<ContentsItem ContentRef="p00004">
<ContentsNumber>2</ContentsNumber>
<ContentsTitle>Short title, commencement and extent</ContentsTitle>
</ContentsItem>
</Contents>
<Primary>
<PrimaryPrelims>
<Title><?start-line?>A
<?new-line?>Bill

<?new-line?>To
</Title>
<Number /><LongTitle><?start-line?><Para>
<Text>Make provision about innovation in medical treatment. <DateOfEnactment><DateText /></DateOfEnactment>
</Text>
</Para>
</LongTitle>
<DateOfEnactment><DateText /></DateOfEnactment>
<PrimaryPreamble>
<EnactingText>
<Para>
<Text>B<SmallCaps>e it enacted</SmallCaps> by the Queen’s most Excellent Majesty, by and with the advice and <?new-line?>consent of the Lords Spiritual and Temporal, and Commons, in this present <?new-line?>Parliament assembled, and by the authority of the same, as follows:—</Text>
</Para>
</EnactingText>
</PrimaryPreamble>
</PrimaryPrelims>
<Body NumberFormat="default">
<P1group id="p00003">
<Title><?start-line?>Responsible innovation</Title>
<P1>
<Pnumber>1</Pnumber>
<P1para>
<P2>
<Pnumber>1</Pnumber>
<P2para>
<Text><?start-line?>The purpose of this Act is to encourage responsible innovation in medical <?new-line?>treatment and to deter reckless departure from standard practice.</Text>
</P2para>
</P2>
<P2>
<Pnumber>2</Pnumber>
<P2para>
<Text><?start-line?>It is not negligent for a doctor to depart from the pre-existing range of accepted <?new-line?>treatments for a condition (standard practice) if the decision to innovate is <?new-line?>taken responsibly.</Text>
</P2para>
</P2>
<P2>
<Pnumber>3</Pnumber>
<P2para>
<Text><?start-line?>A responsible decision to innovate will, in particular, be based on <?new-line?>consideration of—</Text>
<P3>
<Pnumber>a</Pnumber>
<P3para>
<Text><?start-line?>the reasons why the available research or other evidence is insufficient <?new-line?>or unclear including, in particular, whether it is referable to the nature <?new-line?>of the condition (as in, for example, a cancer that affects relatively few <?new-line?>patients),</Text>
</P3para>
</P3>
<P3>
<Pnumber>b</Pnumber>
<P3para>
<Text><?start-line?>the relative risks that are, or can reasonably be expected to be, <?new-line?>associated with the treatment the doctor proposes to apply and other <?new-line?>treatments,</Text>
</P3para>
</P3>
<P3>
<Pnumber>c</Pnumber>
<P3para>
<Text><?start-line?>the relative likely success rates of the treatment the doctor proposes to <?new-line?>apply and other treatments, in the doctor’s reasonable judgement,</Text>
</P3para>
</P3>
<P3>
<Pnumber>d</Pnumber>
<P3para>
<Text><?start-line?>the relative likely consequences of applying, or failing to apply, the <?new-line?>treatment the doctor proposes to apply, and other treatments,</Text>
</P3para>
</P3>
<P3>
<Pnumber>e</Pnumber>
<P3para>
<Text><?start-line?>opinions or requests expressed by or in relation to the patient, and</Text>
</P3para>
</P3>
<P3>
<Pnumber>f</Pnumber>
<P3para>
<Text><?start-line?>any other matter that appears to the doctor to be reasonably necessary <?new-line?>to be considered in order to reach a clinical judgement.</Text>
</P3para>
</P3>
</P2para>
</P2>
<P2>
<Pnumber>4</Pnumber>
<P2para>
<Text><?start-line?>A responsible decision to innovate must be made in accordance with a process <?new-line?>which is accountable, transparent and allows full consideration of all relevant <?new-line?>matters; the process may include, in particular—</Text>
<P3>
<Pnumber>a</Pnumber>
<P3para>
<Text><?start-line?>decision-making within a multi-disciplinary team;</Text>
</P3para>
</P3>
<?new-page?><P3>
<Pnumber>b</Pnumber>
<P3para>
<Text><?start-line?>notification in advance to the doctor’s responsible officer (within the <?new-line?>meaning of Part 5A of the Medical Act 1983);</Text>
</P3para>
</P3>
<P3>
<Pnumber>c</Pnumber>
<P3para>
<Text><?start-line?>explanation to the patient of the doctor’s reasons for proposing to <?new-line?>depart from standard practice, including discussion of any contrary <?new-line?>opinions expressed by the doctor’s colleagues.</Text>
</P3para>
</P3>
</P2para>
</P2>
<P2>
<Pnumber>5</Pnumber>
<P2para>
<Text><?start-line?>Nothing in this section permits a doctor—</Text>
<P3>
<Pnumber>a</Pnumber>
<P3para>
<Text><?start-line?>to provide treatment without consent that is otherwise required by law, <?new-line?>or</Text>
</P3para>
</P3>
<P3>
<Pnumber>b</Pnumber>
<P3para>
<Text><?start-line?>to administer treatment for the purposes of research or for any purpose <?new-line?>other than the best interests of the patient.</Text>
</P3para>
</P3>
</P2para>
</P2>
<P2>
<Pnumber>6</Pnumber>
<P2para>
<Text><?start-line?>In this section—</Text>
<P3>
<Pnumber>a</Pnumber>
<P3para>
<Text><?start-line?>“doctor” means a person listed in the register of medical practitioners <?new-line?>under section 2 of the Medical Act 1983, and</Text>
</P3para>
</P3>
<P3>
<Pnumber>b</Pnumber>
<P3para>
<Text><?start-line?>a reference to treatment of a condition includes a reference to its <?new-line?>management (and a reference to treatment includes a reference to <?new-line?>inaction).</Text>
</P3para>
</P3>
</P2para>
</P2>
</P1para>
</P1>
</P1group>
<P1group id="p00004">
<Title><?start-line?>Short title, commencement and extent</Title>
<P1>
<Pnumber>2</Pnumber>
<P1para>
<P2>
<Pnumber>1</Pnumber>
<P2para>
<Text><?start-line?>This Act may be cited as the Medical Innovation Act 2013.</Text>
</P2para>
</P2>
<P2>
<Pnumber>2</Pnumber>
<P2para>
<Text><?start-line?>This Act comes into force on the day on which it is passed.</Text>
</P2para>
</P2>
<P2>
<Pnumber>3</Pnumber>
<P2para>
<Text><?start-line?>This Act extends to England and Wales, Scotland and Northern Ireland.</Text>
</P2para>
</P2>
</P1para>
</P1>
</P1group>
</Body>
</Primary>
</Legislation>